I trust the 3 Hopper teams and I am convinced they will succeed. At IMU we had no idea where the sp could and would go when they started in 2015. At CHM and RAD we know the valuation for 1 asset was 20c / 60c. Now with a lot more assets and those already progressed but the sp at both at a fraction of the IPO it is a no-brainer to load up at current levels.
IMU, CHM and RAD and maybe even ALA will have steep rise one day, but before that crawling at low levels. In the end, whether average 45 degree gradient or 5 degree and then 85 degree rise, the outcome will be the same. Big Pharma and management will set deal prices and the sp will adjust to that. Until then, patience is required. For LT investors constantly adding at the bottom and then selling at the top will be more rewarding then buying at a constantly increasing rate.
I am still picking up sub 10c for as long as possible. Most of the shares I absorb won't be sold anytime soon but I am honest, a few I will trade in the teens and above if the market allows that. Same applies to IMU and RAD at their levels.
GLTA
CHM Price at posting:
8.7¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)